Cargando…
Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis
PURPOSE: A meta‐analysis was formulated to appraise the diagnostic accuracy of circulating tumor DNA (ctDNA) in hepatocellular carcinoma (HCC). MATERIALS AND METHODS: We enrolled all relevant studies published until September 2019. Four primary subgroups were investigated: the subgroup of quantitati...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013058/ https://www.ncbi.nlm.nih.gov/pubmed/31876977 http://dx.doi.org/10.1002/cam4.2799 |